Firm begins study of sepsis detection device

09/12/2013 | MassDevice.com (Boston)

T2 Biosystems has kicked off a clinical study of its T2Candida test, which is used to detect a fungus often linked to hospital-acquired infections that can trigger sepsis. Data from the trial will be used to support the company's regulatory application for the assay, which takes just about three hours to spot a single colony-forming unit of the Candida fungus in a 1-milliliter blood sample.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA